Financial Performance - The company reported a basic earnings per share of 0.0400 yuan for Q1 2025, representing a 33.33% increase compared to 0.0300 yuan in Q1 2024 [1] - The net profit for Q1 2025 was 0.31 billion yuan, a 6.9% increase from 0.29 billion yuan in Q1 2024 [1] - The total revenue for Q1 2025 was 3.78 billion yuan, showing a slight increase of 1.07% from 3.74 billion yuan in Q1 2024 [1] - The return on equity (ROE) for Q1 2025 was 0.93%, up from 0.91% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 11,698.65 million shares, accounting for 37.8% of the circulating shares, with an increase of 484.66 million shares compared to the previous period [1] - The largest shareholder, Haining Asset Management Company, holds 10,037.88 million shares, representing 32.43% of the total share capital, with no change [2] - New entrants among the top shareholders include Zhong Ge and Chen Hui, while notable exits include Zhang Huwen and Goldman Sachs [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]
钱江生化:2025一季报净利润0.31亿 同比增长6.9%